Janet Woodcock, MD
Former Director CBER and Commissioner FDA
Private
Former long‑time Director of the FDA’s Center for Drug Evaluation and Research (CDER), Dr. Woodcock also served as Principal Deputy Commissioner and Acting Commissioner of the FDA.
U.S. Food and Drug Administration
Over her career she led major regulatory innovations — from the Critical Path Initiative to risk management, generics user fee legislation, and modernization of drug review operations — that reshaped how therapies are developed, evaluated, and brought to patients.
Sessions
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}